News |

The validity of GMP and GDP certificates are extended until the end of 2022.

The European Commission, EMA and the European medicines regulatory network has updated the activities to ensure the availability of medicines during COVID-19 pandemic. The movement restrictions caused by COVID-19  pandemic may have prevented the conduct of  regular on-site GMP or GDP inspections and could therefore result in the expiry of the validity of the periodic GMP or GDP certificates. In order to continue production and distribution activities, the validity of the GMP and GDP certificates issued by the EEA competent authorities will be automatically extended until the end of 2022. The validity of the GMP and GDP certificates was previously extended in spring 2020 until the end of 2021.

https://ec.europa.eu/health/sites/default/files/human-use/docs/guidance_regulatory_covid19_en.pdf